PARK INNOVARE

Blog

Methodically secret: what should you consider with respect to your know-how and trade secrets?

It falls short of a full appreciation of innovation to consider only patentable inventions. Process innovation, for instance, is usually not patentable....

More details More details

Radio-diagnosis paves the way for better therapy

In March 2017, the Strategy Committee at the Paul Scherrer Institute (PSI) gave its green light for a joint initiative with PARK INNOVAARE to join in realizing...

More details

Crystallization at its best

The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...

More details

Electron diffraction opens new possibilities for structure-based drug discovery

Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. The reason why the atomic structure...

More details

State-of-the-art bioinformatics for better drug discovery

The effect a drug has on the human body depends on how well its active substance find its way to the targeted cells in the body, and on the chemical reactions...

More details

The value of the absolute structure

The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical, agrarian and pharmaceutical research....

More details

leadXpro “unlocks” new targets for structure-based drug discovery

One of the most promising groups of drug targets is that of integral membrane proteins. They are responsible for communicating signals from the outside...

More details

Biosensors Technology Platform for efficient lead discovery

In April 2016, the team at InterAx Biotech AG mounted the nameplate of a newly-born company on the wall of PARK INNOVAARE’s deliveryLAB, thus giving...

More details

Dr. Markus Anding: "We are trying to find innovative ways to innovate."

Interview with Dr. Markus Anding, co-founder and Managing Director at Excubate Corporate Startups In our highly competitive world, companies need to...

More details

Video Blog: New SwissFEL technologies and their transfer to broader application

For the PSI’s SwissFEL project, Ampegon and ETH Zurich have developed an innovative short pulse modulator for high power microwave amplifiers. The pulse-to-pulse...

More details

Pharmaceutical mixtures: Excelsus achieves an unprecedented level of detection

X-Ray Powder Diffraction (XRPD) is a powerful technique that exploits the interaction between X-rays and matter to study the structural and microstructural...

More details

Technology as a Tool for Drug Discovery Innovation

Interview with Dr. Oliver Nayler, Head of Cardiovascular & Fibrosis Biology at Actelion Pharmaceutical Ltd. Actelion Pharmaceutical Ltd. is the leading...

More details